Allergan Hits Generic Cos. With Patent Suits Over Viberzi
Allergan USA Inc. has filed patent infringement suits in Delaware federal court to stop a number of Indian competitors from making generic versions of its irritable bowel syndrome drug Viberzi....To view the full article, register now.
Already a subscriber? Click here to view full article